Predictive models for breast cancer-related lymphedema after mastectomy.

Objectives: To establish a nomogram incorporating clinical characteristics to predict the risk of breast cancer-related lymphedema (BCRL).

Methods: In this retrospective study, we included 200 consecutive patients with breast cancer undergoing radical mastectomy from January 2022 to December 2023. Of these, 98 patients diagnosed with BCRL were designated as the experimental group, while 102 patients served as the control group.